NCT01211197 - Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2010

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

C: BI 10773 / metformin tablet

BI 10773 / metformin fixed dose combination tablet after a high fat, high caloric meal

DRUG

B: BI 10773 tablet and metformin tablet

BI 10773 and metformin single tablets, administered together in fasted state

DRUG

A: BI 10773 / metformin tablet

BI 10773 / metformin fixed dose combination tablet in fasted state

Trial Locations (1)

1276.5.1 Boehringer Ingelheim Investigational Site, Biberach